1. Arora T, Loo RL, Anastasovska J, Gibson GR, Tuohy KM, Sharma RK, Swann JR, Deaville ER, Sleeth ML, Thomas EL, Holmes E, Bell JD, Frost G. Differential Effects of Two Fermentable Carbohydrates on Central Appetite Regulation and Body Composition. PLoS One 7: 1–10, 2012.
  2. Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, Malagelada J-R. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 25: 1061–1067, 2010.
  3. Dehghan P, Pourghassem Gargari B, Asgharijafarabadi M. Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial. Diabetes Metab J 3: 55–63, 2013.
  4. Gargari BP, Dehghan P, Aliasgharzadeh A, Jafar-Abadi MA. Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J 37: 140–148, 2013.
  5. Guess ND, Dornhorst A, Oliver N, Bell JD, Thomas EL, Frost GS. A randomized controlled trial: The effect of inulin on weight management and ectopic fat in subjects with prediabetes. Nutr Metab 12: 1–10, 2015.
  6. Guess ND, Dornhorst A, Oliver N, Frost GS. A Randomised Crossover Trial: The Effect of Inulin on Glucose Homeostasis in Subtypes of Prediabetes. Ann Nutr Metab 68: 26–34, 2016.
  7. Kaczmarczyk M, Miller M, Freund G. The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism61: 1058–66, 2012.
  8. Leenen CHM, Dieleman LA. Inulin and Oligofructose in Chronic Inflammatory Bowel Disease. J Nutr 137: 2572S–2575S, 2018.
  9. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: Normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54: 2506–2514, 2011.
  10. Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm MA, Knight SC, Forbes A. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut 55: 348–355, 2006.
  11. Marteau P, Flourié B. Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85: S17, 2008.
  12. Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B. Effects of chicory inulin in constipated elderly people: A double-blind controlled trial. Int J Food Sci Nutr 62: 164–170, 2011.
  13. Morrison DJ, Thomas EL, MacDougall K, Murphy KG, Mt-Isa S, Bloom SR, Dhillo WS, Viardot A, Preston T, Frost G, Psichas A, Zac-Varghese SEK, Ashby D, Bell JD, Blundell JE, Chambers ES, Gibson GR, Clegg S, Morley W, Kolida S, Tedford C, Finlayson GS. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64: 1744–1754, 2014.
  14. Parnell J, Reimer R. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr89: 1751–1759, 2009.
  15. Ripoll C, Flourié B, Megnien S, Hermand O, Janssens M. Gastrointestinal tolerance to an inulin-rich soluble roasted chicory extract after consumption in healthy subjects. Nutrition26: 799–803, 2010.
  16. Sekirov I, Russell S, CM A, BB F. Gut Microbiota in Health and Disease. Physiol Rev 90: 859–904, 2010.
  17. Yurrita LC., Martín ISM. b, Ciudad-Cabañas MJ., Calle-Purón ME., Cabria MH. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials [Eficacia de la ingesta de inulina sobre los indicadores del estre{ñ}imiento cr{ó}nico; un meta-an{á}lisis de ensayos cl{í}nicos. Nutr Hosp 30: 244–252, 2014.